These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 10729993

  • 1. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis.
    Yamada K, Ariyoshi K, Onishi M, Miyajima A, Hayakawa F, Towatari M, Saito H, Oka Y, Asano S, Nosaka T, Kitamura T.
    Int J Hematol; 2000 Jan; 71(1):46-54. PubMed ID: 10729993
    [Abstract] [Full Text] [Related]

  • 2. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
    Spiekermann K, Bagrintseva K, Schwab R, Schmieja K, Hiddemann W.
    Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
    [Abstract] [Full Text] [Related]

  • 3. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
    Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui AL, Kitamura T.
    EMBO J; 1999 Sep 01; 18(17):4754-65. PubMed ID: 10469654
    [Abstract] [Full Text] [Related]

  • 4. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
    Santos SC, Lacronique V, Bouchaert I, Monni R, Bernard O, Gisselbrecht S, Gouilleux F.
    Oncogene; 2001 Apr 19; 20(17):2080-90. PubMed ID: 11360192
    [Abstract] [Full Text] [Related]

  • 5. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
    Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S, Gouilleux F.
    Oncogene; 1999 Jul 22; 18(29):4191-9. PubMed ID: 10435632
    [Abstract] [Full Text] [Related]

  • 6. Differential function of STAT5 isoforms in head and neck cancer growth control.
    Leong PL, Xi S, Drenning SD, Dyer KF, Wentzel AL, Lerner EC, Smithgall TE, Grandis JR.
    Oncogene; 2002 Apr 25; 21(18):2846-53. PubMed ID: 11973644
    [Abstract] [Full Text] [Related]

  • 7. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
    Friedrich K, Wietek S.
    Biol Chem; 2001 Feb 25; 382(2):343-51. PubMed ID: 11308032
    [Abstract] [Full Text] [Related]

  • 8. Constitutive activation of STAT5 by a point mutation in the SH2 domain.
    Ariyoshi K, Nosaka T, Yamada K, Onishi M, Oka Y, Miyajima A, Kitamura T.
    J Biol Chem; 2000 Aug 11; 275(32):24407-13. PubMed ID: 10823841
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS, Wang Y, Erwin-Cohen RA, Aradi J, Monia B, Wang LH, Stepkowski SM, Rui H, Kirken RA.
    J Leukoc Biol; 2002 Oct 11; 72(4):819-28. PubMed ID: 12377952
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Mora LB, Niu G, Sinibaldi D, Bai F, Kraker A, Yu H, Moscinski L, Wei S, Djeu J, Dalton WS, Bhalla K, Loughran TP, Wu J, Jove R.
    Oncogene; 2002 Dec 12; 21(57):8804-16. PubMed ID: 12483533
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
    Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR.
    Cancer Res; 2003 Oct 15; 63(20):6763-71. PubMed ID: 14583472
    [Abstract] [Full Text] [Related]

  • 15. The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.
    Baśkiewicz-Masiuk M, Machaliński B.
    Eur J Haematol; 2004 Jun 15; 72(6):420-9. PubMed ID: 15128421
    [Abstract] [Full Text] [Related]

  • 16. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA, Dorn DC, Schuringa JJ, Chung KY, Morrone G.
    Exp Hematol; 2007 Apr 15; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [Abstract] [Full Text] [Related]

  • 17. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
    Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T.
    J Exp Med; 1999 Apr 19; 189(8):1229-42. PubMed ID: 10209040
    [Abstract] [Full Text] [Related]

  • 18. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
    Nieborowska-Skorska M, Slupianek A, Xue L, Zhang Q, Raghunath PN, Hoser G, Wasik MA, Morris SW, Skorski T.
    Cancer Res; 2001 Sep 01; 61(17):6517-23. PubMed ID: 11522649
    [Abstract] [Full Text] [Related]

  • 19. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
    Chakraborty A, Dyer KF, Tweardy DJ.
    Blood Cells Mol Dis; 2000 Aug 01; 26(4):320-30. PubMed ID: 11042034
    [Abstract] [Full Text] [Related]

  • 20. Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr/Abl kinase activity.
    Jacobberger JW, Sramkoski RM, Frisa PS, Ye PP, Gottlieb MA, Hedley DW, Shankey TV, Smith BL, Paniagua M, Goolsby CL.
    Cytometry A; 2003 Aug 01; 54(2):75-88. PubMed ID: 12879454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.